P. Parham, MHC class I molecules and kirs in human history, health and survival, Nature Reviews Immunology, vol.172, issue.3, pp.201-214, 2005.
DOI : 10.1084/JEM.193.1.135

L. Moretta and A. Moretta, Killer immunoglobulin-like receptors, Current Opinion in Immunology, vol.16, issue.5, pp.626-633, 2004.
DOI : 10.1016/j.coi.2004.07.010
URL : https://hal.archives-ouvertes.fr/hal-00079731

L. L. Lanier, NK CELL RECOGNITION, Annual Review of Immunology, vol.23, issue.1, pp.225-274, 2005.
DOI : 10.1146/annurev.immunol.23.021704.115526

J. H. Yen, B. E. Moore, T. Nakajima, D. Scholl, D. J. Schaid et al., Major Histocompatibility Complex Class I???Recognizing Receptors Are Disease Risk Genes in Rheumatoid Arthritis, The Journal of Experimental Medicine, vol.157, issue.10, pp.1159-1167, 2001.
DOI : 10.1073/pnas.95.7.3798

. Goronzy, Killer cell activating receptors function as costimulatory molecules on CD4+CD28null T cells clonally expanded in rheumatoid arthritis, J Immunol, vol.165, pp.1138-1145, 2000.

M. R. Snyder, M. Lucas, E. Vivier, C. M. Weyand, and J. J. Goronzy, T Cells, The Journal of Experimental Medicine, vol.18, issue.4, pp.437-449, 2003.
DOI : 10.1023/A:1010975124110

A. Boumsell, A. Moretta, M. Bensussan, and . Bagot, CD158k/KIR3DL2 is a new phenotypic marker of Sezary cells: relevance for the diagnosis and follow-up of Sezary syndrome, J Invest Dermatol, vol.122, pp.820-823, 2004.

. Bensussan, Killer cell Ig-like receptors CD158a and CD158b display a coactivatory function, involving the c-Jun NH2-terminal protein kinase signaling pathway, when expressed on malignant CD4+ T cells from a patient with Sezary syndrome, Blood, vol.109, pp.5064-5065, 2007.

N. Anfossi, V. Pascal, E. Vivier, and S. Ugolini, Biology of T memory type 1 cells, Immunological Reviews, vol.181, issue.1, pp.269-278, 2001.
DOI : 10.1034/j.1600-065X.2001.1810123.x

K. J. Warrington, S. Takemura, J. J. Goronzy, and C. M. Weyand, CD4+,CD28? T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems, Arthritis & Rheumatism, vol.273, issue.1, pp.13-20, 2001.
DOI : 10.1002/1529-0131(200101)44:1<13::AID-ANR3>3.0.CO;2-6

L. L. Tyan, P. Lanier, and . Parham, Human diversity in killer cell inhibitory receptor genes, Immunity, vol.7, pp.753-763, 1997.

. Marie-cardine, SC5 mAb represents a unique tool for the detection of extracellular vimentin as a specific marker of Sezary cells, J Immunol, vol.176, pp.652-659, 2006.

M. Vitale, S. Carlomagno, M. Falco, D. Pende, E. Romeo et al., Isolation of a novel KIR2DL3-specific mAb: comparative analysis of the surface distribution and function of KIR2DL2, KIR2DL3 and KIR2DS2, International Immunology, vol.16, issue.10, pp.2-3, 2004.
DOI : 10.1093/intimm/dxh147

C. A. Stewart, F. Laugier-anfossi, F. Vely, X. Saulquin, J. Riedmuller et al., Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors, Proceedings of the National Academy of Sciences, vol.102, issue.37, 2005.
DOI : 10.1073/pnas.0503594102
URL : https://hal.archives-ouvertes.fr/hal-00079731

L. L. Lanier, Natural killer cell receptor signaling, Current Opinion in Immunology, vol.15, issue.3, pp.308-314, 2003.
DOI : 10.1016/S0952-7915(03)00039-6

M. R. Snyder, T. Nakajima, P. J. Leibson, C. M. Weyand, and J. J. Goronzy, Stimulatory Killer Ig-Like Receptors Modulate T Cell Activation through DAP12-Dependent and DAP12-Independent Mechanisms, The Journal of Immunology, vol.173, issue.6, pp.3725-3731, 2004.
DOI : 10.4049/jimmunol.173.6.3725